Evidence map›Paper›PMID 40238580›Full record

ArticleInternational journal of environmental research and public health2025

Evaluation of the Reversibility of Cadmium-Induced Testicular Toxicity Following Recovery Alone or with Zinc Supplementation.

Jihane Ait Benbella, Samy Housbane, Youness Kadil, Fatimaezzahra Kabbali, Ikram Ghicha, Hasnaa Bazhar, Fatiha Bousselham, Afaf Banid, Othmane Hammani, Noureddine Louanjli and 4 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jihane Ait BenbellaLaboratory of Sexual and Reproductive Health, Faculty of Medicine and Pharmacy, Hassan II University Casablanca, Casablanca 20360, Morocco.ORCID 0009-0005-9455-3590
Samy HousbaneDepartment of Medical Informatics, Faculty of Medicine and Pharmacy, Hassan II University Casablanca, Casablanca 20360, Morocco.
Youness KadilLaboratory of Clinical Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Hassan II University Casablanca, Casablanca 20360, Morocco.
Fatimaezzahra KabbaliLaboratory of Clinical Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Hassan II University Casablanca, Casablanca 20360, Morocco.
Ikram GhichaLaboratory of Clinical Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Hassan II University Casablanca, Casablanca 20360, Morocco.
Hasnaa BazharLaboratory of Clinical Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Hassan II University Casablanca, Casablanca 20360, Morocco.
Fatiha BousselhamLaboratory of Clinical Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Hassan II University Casablanca, Casablanca 20360, Morocco.
Afaf BanidLaboratory of Clinical Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Hassan II University Casablanca, Casablanca 20360, Morocco.
Othmane HammaniNational Center for Scientific and Technical Research (CNRST), Rabat 10102, Morocco.ORCID 0000-0002-4154-5993
Noureddine LouanjliLabomac IVF Center and Clinical Laboratory Medicine, Casablanca 20120, Morocco.
Mehdi KarkouriDepartment of Pathology, CHU Ibn Rochd, Casablanca 20100, Morocco.
Abderrahmane MelloukiDepartment of Pathology, CHU Ibn Rochd, Casablanca 20100, Morocco.
Houda FilaliLaboratory of Clinical Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Hassan II University Casablanca, Casablanca 20360, Morocco.
Rachid AboutaiebLaboratory of Sexual and Reproductive Health, Faculty of Medicine and Pharmacy, Hassan II University Casablanca, Casablanca 20360, Morocco.ORCID 0000-0002-9287-0331

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cadmium (Cd) is a toxic heavy metal that disrupts spermatogenesis and steroidogenesis due to its long half-life. This study evaluated the impact of recovery alone or with zinc (Zn) supplementation on Cd-induced testicular toxicity. A total of 42 pubertal male Wistar rats were divided into seven groups of six rats each. The control group (1) received NaCl (0.9%). Groups 2, 3, and 4 were treated with Cd 10 μg/kg/d by intraperitoneal injection for 1, 2, and 3 months respectively. Group 5 received Cd for 3 months with a recovery period of 1 month; Group 6 was exposed to Cd for 3 months, followed by a 1-month recovery period combined with Zn supplementation. (0.5 mg/kg/d). The last group was treated with zinc at a dose of 0.5 mg/kg/day for one month. The results showed decreased body weight, testicular and epididymal weight, testicular dimensions, and sperm parameters, along with Cd accumulation in the testes. Cd caused testicular damage and reduced serum testosterone levels, with more pronounced effects in the 3-month treatment group. Recovery alone did not significantly reverse Cd's toxic effects, whereas Zn supplementation mitigated most of the damage. Recovery combined with Zn supplementation was more effective in correcting Cd-induced testicular toxicity than recovery alone.

Indexed as

CadmiumTestisZincAnimalsDietary SupplementsMaleOrgan SizeRatsRats, WistarTestosteroneCadmiumTestosteroneZinccadmiumrecoverytesticular toxicityzinc

Identifiers

PMID40238580
PMCPMC11942505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.